CSIMarket Company Name, Ticker, Industry, else..
 
Privia Health Group Inc   (NASDAQ: PRVA)
Other Ticker:  
 
 

Privia Health Group Inc Income Statement Quarterly

PRVA


 

Select the Financial Report:   Period:

New: More PRVA's historic Income Statements >>

INCOME STATEMENT
(Quarterly GAAP In millions $)

 (Mar 31 2025)
Q1 2025		 (Dec 31 2024)
Q4 2024		 (Sep 30 2024)
Q3 2024		 (Jun 30 2024)
Q2 2024		 (Mar 31 2024)
Q1 2024
Revenue From Contract With Customer Including Assessed Tax 480.10 437.92 422.33 415.24
Total Revenue 480.10 460.90 437.92 422.33 415.24
Liability for Future Policy Benefits, Period Expense (Income) 374.81 353.16 336.50 322.54 320.34
Gross Profit 105.29 107.74 101.42 99.79 94.91
Selling, Administration, Marketing 6.92 6.46 7.05 6.85 6.09
Depriciation & Amortization 1.90 1.83 1.80 1.82 1.82
Research & development - - - - -
Restructuring, Accretion & impairment charges - - - - -
Other operatinig exp. /-income 91.25 94.19 86.76 86.02 86.18
Unusual Expense /-Income - - - - -
Total operating costs including COS 474.88 455.65 432.11 417.23 414.42
Operating income/-loss 5.22 5.25 5.81 5.10 0.82
Other Deductions / - Income
Interest expense - 2.98 - - 2.98
Interest income - - - - -
Net interest expense/-income - 2.98 - - -2.98
Loss/ -Gain on Investment - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -2.93 -5.76 -2.16 -2.97 -5.97
Total costs & expenses 471.95 452.88 429.94 414.26 411.44
Income /-loss before income taxes 8.15 8.02 7.98 8.06 3.81
Income taxes expenses/-benefit 2.10 2.66 4.00 3.42 0.75
Income after income taxes 6.05 5.37 3.98 4.64 3.06
Net income/-loss of other equity 0.00 0.00 - 0.00 -
Income/-loss from cont. Ops. 6.05 5.37 3.98 4.64 3.06
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 6.05 5.37 3.98 4.64 3.06
Non-controlling interests 1.83 0.97 0.44 1.18 0.07
Preferred dividends - - - - -
Other - - - - -
Income/-loss to shareholder 4.22 4.40 3.54 3.47 2.98
EBIT 8.15 11.01 7.98 8.06 0.82
EBITD 8.38 11.23 8.27 8.36 1.12
EBITDA 10.05 12.84 9.77 9.88 2.64


Per Share (GAAP Quarterly, in $) (Mar 31 2025)
Q1 2025		 (Dec 31 2024)
Q4 2024		 (Sep 30 2024)
Q3 2024		 (Jun 30 2024)
Q2 2024		 (Mar 31 2024)
Q1 2024
Basic EPS (excl. extra items) 0.03 0.04 0.03 0.03 0.03
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 0.03 0.04 0.03 0.03 0.03
Basic shares outstanding (Mill. of Units) 120.62 120.15 119.66 119.30 118.51
   EPS other shares - - - - -
Diluted Net EPS 0.03 0.03 0.03 0.03 0.02
Diluted average shares (Mill. of Units) 127.75 130.77 125.75 125.32 125.05
Dividend per share - - - - -